Ikarian Capital »

Sagimet Biosciences Inc-a shares owned by Ikarian Capital

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 413k 5.42

More positions owned by Ikarian Capital

Krystal Biotech Put Option (KRYS)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Alnylam Pharmaceuticals (ALNY)
Crinetics Pharmaceuticals In (CRNX)
Sarepta Therapeutics (SRPT)
Corcept Therapeutics Incorporated Put Option (CORT)
Tarsus Pharmaceuticals (TARS)
Disc Medicine (IRON)
Soleno Therapeutics (SLNO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Astrazeneca Sponsored Adr Call Option (AZN)
Bridgebio Pharma (BBIO)
Eyepoint Pharmaceuticals Com New (EYPT)
Biomea Fusion Put Option (BMEA)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a